120 related articles for article (PubMed ID: 6342123)
1. Breakdown product of factor B as an index of complement activation in lepromatous leprosy and its relation with bacillary load.
Saha K; Sharma V; Chakrabarty AK; Sehgal VN
Scand J Immunol; 1983 Jan; 17(1):37-43. PubMed ID: 6342123
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of complement components in the course of type I (Lepra) and type II (ENL) reactions.
Sehgal VN; Sharma V; Sharma VK
Int J Dermatol; 1989; 28(1):32-5. PubMed ID: 2783924
[TBL] [Abstract][Full Text] [Related]
3. An appraisal of third complement component (C3) and breakdown product (C3d) in erythema nodosum leprosum (ENL).
Saha K; Chakraborty AK; Sharma V; Sehgal VN
Lepr Rev; 1982 Dec; 53(4):253-60. PubMed ID: 6984124
[No Abstract] [Full Text] [Related]
4. Numerical changes in T cell subsets (T gamma and T mu) in leprosy patients.
Izumi S; Sugiyama K; Matsumoto Y; Nagai T
Microbiol Immunol; 1980; 24(8):733-40. PubMed ID: 6968392
[TBL] [Abstract][Full Text] [Related]
5. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
[TBL] [Abstract][Full Text] [Related]
6. Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum.
Valentijn RM; Faber WR; Lai A Fat RF; Chan Pin Jie JC; Daha MR; van Es LA
Clin Immunol Immunopathol; 1982 Feb; 22(2):194-202. PubMed ID: 6980747
[No Abstract] [Full Text] [Related]
7. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
8. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
9. Influence of age and sex on serum complement components in children.
Roach B; Kim Y; Jerome E; Michael AF
Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
[TBL] [Abstract][Full Text] [Related]
10. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
11. Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
Bansal F; Narang T; Dogra S; Vinay K; Chhabra S
Indian J Dermatol Venereol Leprol; 2018; 84(5):573-577. PubMed ID: 28656911
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes and complement hypercatabolism in patients with leprosy.
Bjorvatn B; Barnetson RS; Kronvall G; Zubler RH; Lambert PH
Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological studies of skin biopsies from patients with lepromatous leprosy.
Mshana RN; Humber DP; Belehu A; Harboe M
J Clin Immunol; 1983 Jan; 3(1):22-9. PubMed ID: 6338025
[TBL] [Abstract][Full Text] [Related]
14. [Immune complexes and complement in leprosy (author's transl)].
Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
[TBL] [Abstract][Full Text] [Related]
15. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid.
Schenkein HA; Genco RJ
J Periodontol; 1977 Dec; 48(12):778-84. PubMed ID: 338883
[TBL] [Abstract][Full Text] [Related]
16. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
Jain VK; Verma KC; Aggarwal SS
Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulation abnormalities in multibacillary leprosy patients.
Silva DSD; Teixeira LAC; Beghini DG; Ferreira ATDS; Pinho MBM; Rosa PS; Ribeiro MR; Freire MDC; Hacker MA; Nery JADC; Pessolani MCV; Tovar AMF; Sarno EN; Perales J; Bozza FA; Esquenazi D; Monteiro RQ; Lara FA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006214. PubMed ID: 29565968
[TBL] [Abstract][Full Text] [Related]
18. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
19. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
[TBL] [Abstract][Full Text] [Related]
20. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction.
Sehgal VN; Sharma V; Sharma VK
Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
